fendiline has been researched along with Urinary Bladder Neoplasms in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jan, CR | 1 |
| Yu, CC | 1 |
| Huang, JK | 1 |
1 other study available for fendiline and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death.
Topics: Anti-Arrhythmia Agents; Calcium; Carcinoma, Transitional Cell; Cell Death; Cell Survival; Dose-Respo | 2001 |